• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂膜炎样坏死性溃疡:抗TNFα治疗是否可行?

Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?

作者信息

Guedes Rita, Leite Inês, Baptista Armando, Rocha Natividade

机构信息

Dermatology Department, Centro Hospitalar de Vila Nova de Gaia Espinho, Rua Conceição Fernandes, 4434-502 Vila Nova de Giaa, Portugal.

出版信息

Case Rep Med. 2012;2012:854738. doi: 10.1155/2012/854738. Epub 2012 May 23.

DOI:10.1155/2012/854738
PMID:22675367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3366227/
Abstract

Necrobiosis lipoidica is a rare granulomatous and inflammatory disease. Its management is particularly difficult when ulceration is present. The authors describe the clinical case of a 65-year-old female patient with necrobiosis lipoidica, who had been submitted in the past to several topical and systemic treatments with little or no improvement. She started treatment with subcutaneous etanercept and showed significant improvement without adverse events until today. The aim of this article is to report a valid and efficient alternative treatment to recalcitrant cases.

摘要

类脂质渐进性坏死是一种罕见的肉芽肿性炎症性疾病。当出现溃疡时,其治疗尤为困难。作者描述了一例65岁患有类脂质渐进性坏死的女性患者的临床病例,该患者过去曾接受过多种局部和全身治疗,但改善甚微或没有改善。她开始接受皮下注射依那西普治疗,至今显示出显著改善且无不良事件。本文的目的是报告一种针对难治性病例的有效替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d7/3366227/da727e1e07a1/CRIM2012-854738.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d7/3366227/da53c45ff53a/CRIM2012-854738.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d7/3366227/da727e1e07a1/CRIM2012-854738.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d7/3366227/da53c45ff53a/CRIM2012-854738.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d7/3366227/da727e1e07a1/CRIM2012-854738.002.jpg

相似文献

1
Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?脂膜炎样坏死性溃疡:抗TNFα治疗是否可行?
Case Rep Med. 2012;2012:854738. doi: 10.1155/2012/854738. Epub 2012 May 23.
2
Anti-TNFα treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature.抗TNFα治疗顽固性糖尿病性类脂质渐进性坏死:一例报告及文献复习
Metabolism. 2016 Apr;65(4):569-73. doi: 10.1016/j.metabol.2015.12.014. Epub 2016 Jan 7.
3
The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.抗肿瘤坏死因子在伤口愈合中的作用:阿达木单抗治疗难治性溃疡性类脂质渐进性坏死的病例报告及文献综述
SAGE Open Med Case Rep. 2019 Oct 18;7:2050313X19881594. doi: 10.1177/2050313X19881594. eCollection 2019.
4
Ulcerative necrobiosis lipoidica responsive to colchicine.溃疡性脂性坏死性类脂质渐进性坏死对秋水仙碱有反应。
Australas J Dermatol. 2012 Aug;53(3):e54-7. doi: 10.1111/j.1440-0960.2011.00768.x.
5
Treatment-resistant ulcerative necrobiosis lipoidica in a diabetic patient responsive to ustekinumab.对优特克单抗有反应的糖尿病患者中的难治性溃疡性类脂质渐进性坏死
Dermatol Online J. 2019 Aug 15;25(8):13030/qt2q05z4rw.
6
Ustekinumab to target granulomatous dermatitis in recalcitrant ulcerative necrobiosis lipoidica: case report and proposed mechanism.乌司奴单抗治疗顽固性溃疡性类脂质渐进性坏死中的肉芽肿性皮炎:病例报告及可能机制
Dermatol Online J. 2017 Jul 15;23(7):13030/qt3k32k916.
7
Ulcerative necrobiosis lipoidica successfully treated with photodynamic therapy: case report and literature review.光动力疗法成功治疗溃疡性脂性坏死:病例报告及文献复习。
Photodiagnosis Photodyn Ther. 2014 Dec;11(4):516-8. doi: 10.1016/j.pdpdt.2014.08.002. Epub 2014 Aug 21.
8
Necrobiosis lipoidica in a Nigerian woman - Report of a case.一名尼日利亚女性的类脂质渐进性坏死——病例报告
Niger J Clin Pract. 2019 Nov;22(11):1626-1628. doi: 10.4103/njcp.njcp_40_19.
9
Conventional Photodynamic Therapy for Necrobiosis Lipoidica: Successful Treatment in a Series of 4 Cases.常规光动力疗法治疗类脂质渐进性坏死:4 例成功治疗。
Actas Dermosifiliogr (Engl Ed). 2020 Sep;111(7):605-608. doi: 10.1016/j.ad.2019.01.022. Epub 2020 Jun 20.
10
Ulcerating necrobiosis lipoidica resolving in response to cyclosporine-A.环孢素A治疗下溃疡型类脂质渐进性坏死的消退
Dermatol Online J. 1997 Mar;3(1):2.

引用本文的文献

1
Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review.单克隆抗体在伤口愈合炎症管理中的应用:文献综述更新
J Clin Med. 2024 Jul 12;13(14):4089. doi: 10.3390/jcm13144089.
2
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience.探讨光动力学疗法治疗类脂质渐进性坏死:多中心真实世界经验。
Int J Mol Sci. 2024 Mar 23;25(7):3608. doi: 10.3390/ijms25073608.
3
The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.

本文引用的文献

1
Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature.生物制剂治疗类脂质坏死性皮肤异色病:一例接受依那西普治疗的溃疡病例及文献复习。
Dermatology. 2010;221(2):117-21. doi: 10.1159/000314694. Epub 2010 Jun 25.
2
Treatment of necrobiosis lipoidica with etanercept and adalimumab.用依那西普和阿达木单抗治疗类脂质渐进性坏死。
Dermatol Online J. 2009 Dec 15;15(12):12.
3
Off-label dermatologic uses of anti-TNF-a therapies.抗TNF-α疗法的非标签皮肤科应用。
抗肿瘤坏死因子在伤口愈合中的作用:阿达木单抗治疗难治性溃疡性类脂质渐进性坏死的病例报告及文献综述
SAGE Open Med Case Rep. 2019 Oct 18;7:2050313X19881594. doi: 10.1177/2050313X19881594. eCollection 2019.
4
Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.类脂质渐进性坏死的治疗方式:简明系统评价
Dermatol Reports. 2015 Jun 8;7(2):5749. doi: 10.4081/dr.2015.5749. eCollection 2015 May 21.
5
Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.溃疡性类脂质渐进性坏死作为慢性腿部溃疡的罕见病因:10例患者的病例报告系列
Int Wound J. 2015 Oct;12(5):548-54. doi: 10.1111/iwj.12159. Epub 2013 Oct 7.
J Cutan Med Surg. 2005 Dec;9(6):296-302. doi: 10.1007/s10227-005-0110-7.
4
Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.使用肿瘤坏死因子拮抗剂依那西普治疗类脂质渐进性坏死。
J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S120-1. doi: 10.1016/j.jaad.2005.11.1042.
5
Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy.采用分层自体皮移植和免疫调节疗法联合治疗泛发性类脂质渐进性坏死。
Int J Dermatol. 2004 Nov;43(11):852-4. doi: 10.1111/j.1365-4632.2004.02120.x.
6
Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica.英夫利昔单抗:治疗溃疡性类脂质渐进性坏死的一种有前景的新选择。
Dermatology. 2003;206(2):180-1. doi: 10.1159/000068465.